Cisplatin Shortage Nearly Resolved; Supplies of Carboplatin, Methotrexate Increasing
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Asian patients with de novo metastatic prostate cancer have better survival outcomes than White patients with the disease, according to a new study.
Atezolizumab, given with or without radiotherapy, has demonstrated some activity in a subset of patients with penile cancer.
Black and Hispanic patients have a higher risk of death from second primary cancers than White and Asian/Pacific Islander patients, new data suggest.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.